We use cookies to offer you the best experience on our site. You can find out more about the cookies we use or disable them in the Cookie settings
DNA Analysis
The advances in treatments have made it possible to include new genetic diseases to the panel of diseases eligible for neonatal screening. These diseases can be detected by finding the site of the specific DNA mutation.
ZenTech is developing its range and expanding its technology portfolio by adding qPCR to its already reputed enzyme range. The DNA analysis range includes kits for first-line neonatal screening suitable for the use of dried blood samples.